Raloxifene, commonly known by the brand name Evista, is a selective estrogen receptor modulator (SERM) that serves multiple purposes. Primarily, it is used to treat and prevent osteoporosis in postmenopausal women, helping to maintain bone density and reduce the risk of fractures. Additionally, Raloxifene is utilized to reduce the risk of invasive breast cancer in postmenopausal women who either have osteoporosis or are at high risk for breast cancer. By mimicking estrogen's beneficial effects on bones and breast tissue while minimizing its harmful effects on the uterus and breast, Raloxifene provides a targeted approach to women's health. visit dosepharmacy for more information